BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2265135)

  • 1. Empiric treatment of infection during granulocytopenia.
    Klastersky J
    Ann Oncol; 1990 Jul; 1(4):255-61. PubMed ID: 2265135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative bacteremia.
    Schimpff SC
    Support Care Cancer; 1993 Jan; 1(1):5-18. PubMed ID: 8143100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Joshi JH; Newman KA; Brown BW; Finley RS; Ruxer RL; Moody MA; Schimpff SC
    Support Care Cancer; 1993 Jul; 1(4):186-94. PubMed ID: 8193880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved prognosis for granulocytopenic patients with gram-negative bacteremia.
    Love LJ; Schimpff SC; Schiffer CA; Wiernik PH
    Am J Med; 1980 May; 68(5):643-8. PubMed ID: 7377220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotherapy in the patient with granulocytopenic cancer].
    Van Der Auwera P; Meunier F
    Pathol Biol (Paris); 1990 Apr; 38(4):302-6. PubMed ID: 2198526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.
    Schimpff SC; Landesman S; Hahn DM; Standiford HC; Fortner CL; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1976 Nov; 10(5):837-44. PubMed ID: 795372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Newman KA; Moody MR; Wharton R; Standiford HC; Schimpff SC
    Am J Med; 1986 May; 80(5C):96-100. PubMed ID: 3717193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
    Viscoli C; Bruzzi P; Castagnola E; Boni L; Calandra T; Gaya H; Meunier F; Feld R; Zinner S; Klastersky J
    Eur J Cancer; 1994; 30A(4):430-7. PubMed ID: 8018397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. After empiric therapy: what to do until the granulocyte comes back.
    Pizzo PA
    Rev Infect Dis; 1987; 9(1):214-9. PubMed ID: 3547574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
    Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC
    Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment of infections in neutropenic patients with cancer.
    Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 1():S21-31. PubMed ID: 6342096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patients.
    Gill FA; Robinson R; Maclowry JD; Levine AS
    Cancer; 1977 Apr; 39(4):1704-9. PubMed ID: 856452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.